uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
20.68
+1.55 (8.10%)
At close: May 4, 2026, 4:00 PM EDT
20.27
-0.41 (-2.00%)
Pre-market: May 5, 2026, 7:51 AM EDT
uniQure Market Cap
uniQure has a market cap or net worth of $1.3 billion as of May 5, 2026. Its market cap has increased by 85.42% in one year.
Market Cap
1.30B
Enterprise Value
1.22B
1-Year Change
85.42%
Ranking
Category
Stock Price
$20.68
Market Cap Chart
Since March 15, 2017, uniQure's market cap has increased from $161.10M to $1.30B, an increase of 709.14%. That is a compound annual growth rate of 25.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 1.29B | -13.25% |
| Dec 31, 2025 | 1.49B | 73.16% |
| Dec 31, 2024 | 860.80M | 165.93% |
| Dec 29, 2023 | 323.70M | -69.50% |
| Dec 30, 2022 | 1.06B | 10.73% |
| Dec 31, 2021 | 958.50M | -40.38% |
| Dec 31, 2020 | 1.61B | -48.57% |
| Dec 31, 2019 | 3.13B | 190.93% |
| Dec 31, 2018 | 1.07B | 78.06% |
| Dec 29, 2017 | 603.40M | 274.55% |
| Mar 15, 2017 | 161.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 1.39B |
| KalVista Pharmaceuticals | 1.37B |
| Corvus Pharmaceuticals | 1.35B |
| GH Research | 1.35B |
| Savara | 1.34B |
| ArriVent BioPharma | 1.34B |
| Novavax | 1.32B |
| MapLight Therapeutics | 1.30B |